Tag Archives: Should

Cardiovascular Comorbidity Screening Should Be Conducted in COPD With Obesity

January 16, 2019 Share this content: Obesity is most prevalent in patients with COPD GOLD I and GOLD II stages. In obese patients with chronic obstructive pulmonary disease (COPD), cardiovascular and metabolic comorbidities, particularly hypertension and diabetes, are highly prevalent, and active screening for these disorders should be a priority among healthcare professionals who treat… Read More »

Part II | MedPAC’s Proposed “Reforms” Should Be Tested Before They’re Implemented: CMS’s Hospital Readmissions Reduction Program Is Exhibit A

By KIP SULLIVAN JD  The Hospital Readmissions Reduction Program (HRRP), one of numerous pay-for-performance (P4P) schemes authorized by the Affordable Care Act, was sprung on the Medicare fee-for-service population on October 1, 2012 without being pre-tested and with no other evidence indicating what it is hospitals are supposed to do to reduce readmissions. Research on the… Read More »